Page last updated: 2024-08-24

sipatrigine and Epilepsy

sipatrigine has been researched along with Epilepsy in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (20.00)18.2507
2000's3 (60.00)29.6817
2010's1 (20.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Anger, T; Madge, DJ; Mulla, M; Riddall, D1
Bennis, K; Ducki, S; Lesage, F; Vivier, D1
Bernardi, G; Caputi, L; Hainsworth, AH; Lavaroni, F; Martella, G; Mercuri, NB; Spadoni, F; Stefani, A1
Meldrum, BS1
Bernardi, G; Calabresi, P; Centonze, D; Giacomini, P; Hainsworth, AH; Leach, MJ; Marfia, GA; Saulle, E; Spadoni, F; Stefani, A1

Reviews

3 review(s) available for sipatrigine and Epilepsy

ArticleYear
Medicinal chemistry of neuronal voltage-gated sodium channel blockers.
    Journal of medicinal chemistry, 2001, Jan-18, Volume: 44, Issue:2

    Topics: Amyotrophic Lateral Sclerosis; Analgesics; Anticonvulsants; Epilepsy; Humans; Ion Channel Gating; Models, Molecular; Mutation; Nerve Tissue Proteins; Neuroprotective Agents; Protein Binding; Sodium Channel Blockers; Sodium Channels; Stroke

2001
Perspectives on the Two-Pore Domain Potassium Channel TREK-1 (TWIK-Related K(+) Channel 1). A Novel Therapeutic Target?
    Journal of medicinal chemistry, 2016, 06-09, Volume: 59, Issue:11

    Topics: Arrhythmias, Cardiac; Depression; Epilepsy; Humans; Inflammation; Models, Molecular; Molecular Structure; Neuroprotective Agents; Pain; Potassium Channels, Tandem Pore Domain; Structure-Activity Relationship

2016
The role of glutamate in epilepsy and other CNS disorders.
    Neurology, 1994, Volume: 44, Issue:11 Suppl 8

    Topics: Animals; Central Nervous System Diseases; Epilepsy; Glutamic Acid; Humans; Lamotrigine; Mice; N-Methylaspartate; Parkinson Disease; Piperazines; Pyrimidines; Rats; Receptors, AMPA; Receptors, Kainic Acid; Receptors, N-Methyl-D-Aspartate; Sodium Channels; Triazines

1994

Other Studies

2 other study(ies) available for sipatrigine and Epilepsy

ArticleYear
Lamotrigine derivatives and riluzole inhibit INa,P in cortical neurons.
    Neuroreport, 2002, Jul-02, Volume: 13, Issue:9

    Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Anticonvulsants; Cerebral Cortex; Dose-Response Relationship, Drug; Epilepsy; Lamotrigine; Male; Membrane Potentials; Neural Inhibition; Neuroprotective Agents; Piperazines; Pyramidal Cells; Pyrimidines; Rats; Rats, Wistar; Riluzole; Sodium; Sodium Channel Blockers; Sodium Channels; Triazines

2002
Electrophysiology of sipatrigine: a lamotrigine derivative exhibiting neuroprotective effects.
    Experimental neurology, 2000, Volume: 162, Issue:1

    Topics: Action Potentials; Animals; Anticonvulsants; Brain Chemistry; Calcium Channels; Corpus Striatum; Epilepsy; Excitatory Postsynaptic Potentials; In Vitro Techniques; Lamotrigine; Male; Neurons; Neuroprotective Agents; Patch-Clamp Techniques; Piperazines; Pyrimidines; Rats; Rats, Wistar; Sodium; Stroke; Tetrodotoxin; Triazines

2000